Innovation
22 patent families (12 granted) — focus: Human necessities; filing pace steady. Cited 392 times.
| Year | Filings |
|---|---|
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 7 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 7 |
| 2024 | 4 |
| 2025 | 8 |
| 2026 | 2 |
Social engagement
Social engagement: 14K social following, 8 posts in the last 12 months — below the industry typical range.
Investor mix
10 investors on record; lead investors include Innogest Capital, VI Ventures, Clal Biotechnology Industries, Sofinnova Partners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 70% |
| Private equity | 1 | 10% |
| Bank & private debt | 1 | 10% |
| Other / undisclosed | 1 | 10% |
Recent activity
24 Jun 2026
Event
ShortCut Leaflet Modification Sessions
21 Jun 2026
Event
NYValves 2026
11 Jun 2026
Partnership
Geisinger Danville Medical Center